{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:35:16Z","timestamp":1777628116615,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107915","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:30:38Z","timestamp":1777426238000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes and Therapeutic Response in Adult TFE3-Related Renal Cell Carcinoma: A Case Series From a Tertiary Cancer Center in Southern India"],"prefix":"10.7759","author":[{"given":"Kiran N","family":"Chavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi K","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelima","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Renal carcinomas associated with Xp11.2 translocations\/TFE3 gene fusions","author":"Argani P","year":"2004","unstructured":"Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations\/TFE3 gene fusions. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein J, Sesterhenn I (ed): International Agency for Research on Cancer, Lyon, France; 2004. 7:37-8."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs: part A: renal, penile, and testicular tumours","volume":"70","author":"Moch H","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs: part A: renal, penile, and testicular tumours. Eur Urol. 2016, 70:93-105. 10.1016\/j.eururo.2016.02.029","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081110","article-title":"MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge","volume":"11","author":"Cali\u00f2 A","year":"2019","unstructured":"Cali\u00f2 A, Segala D, Munari E, Brunelli M, Martignoni G. MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge. Cancers. 2019, 11:1110. 10.3390\/cancers11081110","journal-title":"Cancers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.26.15294","article-title":"Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas","volume":"93","author":"Weterman MA","year":"1996","unstructured":"Weterman MA, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci U S A. 1996, 93:15294-8. 10.1073\/pnas.93.26.15294","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/810590","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: a rare case report with review of the literature","volume":"2013","author":"Ahluwalia P","year":"2013","unstructured":"Ahluwalia P, Nair B, Kumar G. Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: a rare case report with review of the literature. Case Rep Urol. 2013, 2013:810590. 10.1155\/2013\/810590","journal-title":"Case Rep Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of tumours of the urinary system and male genital organs: part A: renal, penile, and testicular tumours","volume":"82","author":"Moch H","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, et al.. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs: part A: renal, penile, and testicular tumours. Eur Urol. 2022, 82:458-68. 10.1016\/j.eururo.2022.06.016","journal-title":"Eur Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1497","article-title":"Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: a case report","volume":"8","author":"Pan X","year":"2018","unstructured":"Pan X, Quan J, Zhao L, Li W, Wei B, Yang S, Lai Y. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: a case report. Mol Clin Oncol. 2018, 8:83-5. 10.3892\/mco.2017.1497","journal-title":"Mol Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37072","article-title":"Xp11.2 translocation renal cell carcinoma: a rare renal cell carcinoma","volume":"15","author":"Kalita P","year":"2023","unstructured":"Kalita P, Dey B, Saurabh A, Chishti SF. Xp11.2 translocation renal cell carcinoma: a rare renal cell carcinoma. Cureus. 2023, 15:e37072. 10.7759\/cureus.37072","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-05290-w","article-title":"Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma","volume":"42","author":"Mu\u00f1oz Bastidas C","year":"2024","unstructured":"Mu\u00f1oz Bastidas C, Tapia MT, L\u00f3pez AC, et al.. Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma. World J Urol. 2024, 42:603. 10.1007\/s00345-024-05290-w","journal-title":"World J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59162-5","article-title":"Comparative clinicopathologic characteristics and outcomes of paediatric and adult Xp11 translocation renal cell carcinomas: a retrospective multicentre study in China","volume":"10","author":"Ma W","year":"2020","unstructured":"Ma W, Liu N, Zhuang W, et al.. Comparative clinicopathologic characteristics and outcomes of paediatric and adult Xp11 translocation renal cell carcinomas: a retrospective multicentre study in China. Sci Rep. 2020, 10:2249. 10.1038\/s41598-020-59162-5","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166897","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusions: clinical features, treatments and prognosis","volume":"11","author":"Liu N","year":"2016","unstructured":"Liu N, Wang Z, Gan W, et al.. Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusions: clinical features, treatments and prognosis. PLoS One. 2016, 11:e0166897. 10.1371\/journal.pone.0166897","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-01060-1","article-title":"Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation\/TFE3 gene fusion renal cell carcinomas","volume":"22","author":"Zhou J","year":"2022","unstructured":"Zhou J, Zhao L, Yang Z, Chen Y, Wu X, Xue W. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation\/TFE3 gene fusion renal cell carcinomas. BMC Urol. 2022, 22:109. 10.1186\/s12894-022-01060-1","journal-title":"BMC Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-018-0731-y","article-title":"Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature","volume":"13","author":"Jing H","year":"2018","unstructured":"Jing H, Wei H, Yuan H, Li Y, Li N, Mu D. Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature. Diagn Pathol. 2018, 13:51. 10.1186\/s13000-018-0731-y","journal-title":"Diagn Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.784993","article-title":"Xp11.2 translocation renal cell carcinoma with TFE3 rearrangement: distinct morphological features and prognosis with different fusion partners","volume":"11","author":"Ge Y","year":"2021","unstructured":"Ge Y, Lin X, Zhang Q, Lin D, Luo L, Wang H, Li Z. Xp11.2 translocation renal cell carcinoma with TFE3 rearrangement: distinct morphological features and prognosis with different fusion partners. Front Oncol. 2021, 11:784993. 10.3389\/fonc.2021.784993","journal-title":"Front Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1731264","article-title":"Study of treatment outcome in adults with TFE-related RCC","volume":"10","author":"Singh AC","year":"2021","unstructured":"Singh AC, Pal M, Kapoor A, et al.. Study of treatment outcome in adults with TFE-related RCC. South Asian J Cancer. 2021, 10:92-6. 10.1055\/s-0041-1731264","journal-title":"South Asian J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_385_22","article-title":"MiT family translocation-associated renal cell carcinoma: a report of two cases in children","volume":"67","author":"Mukherjee S","year":"2024","unstructured":"Mukherjee S, Basu K, Basu KS, Chatterjee U. MiT family translocation-associated renal cell carcinoma: a report of two cases in children. Indian J Pathol Microbiol. 2024, 67:469-71. 10.4103\/ijpm.ijpm_385_22","journal-title":"Indian J Pathol Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58470","article-title":"The WHO 2022 classification of renal neoplasms (5th edition): salient updates","volume":"16","author":"Goswami PR","year":"2024","unstructured":"Goswami PR, Singh G, Patel T, Dave R. The WHO 2022 classification of renal neoplasms (5th edition): salient updates. Cureus. 2024, 16:e58470. 10.7759\/cureus.58470","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-025-05927-4","article-title":"Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching","volume":"43","author":"Han W","year":"2025","unstructured":"Han W, Peng K, Shen Q, et al.. Clinical characteristics and survival outcomes of TFE3-rearranged renal cell carcinoma: a retrospective study compared with clear cell renal cell carcinoma using propensity score matching. World J Urol. 2025, 43:654. 10.1007\/s00345-025-05927-4","journal-title":"World J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.610360","article-title":"Factors associated with survival from Xp11.2 translocation renal cell carcinoma diagnosis: a systematic review and pooled analysis","volume":"27","author":"Wu Y","year":"2021","unstructured":"Wu Y, Chen S, Zhang M, et al.. Factors associated with survival from Xp11.2 translocation renal cell carcinoma diagnosis: a systematic review and pooled analysis. Pathol Oncol Res. 2021, 27:610360. 10.3389\/pore.2021.610360","journal-title":"Pathol Oncol Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network","volume":"21","author":"Malouf GG","year":"2010","unstructured":"Malouf GG, Camparo P, Oudard S, et al.. Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol. 2010, 21:1834-8. 10.1093\/annonc\/mdq029","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474422-clinical-outcomes-and-therapeutic-response-in-adult-tfe3-related-renal-cell-carcinoma-a-case-series-from-a-tertiary-cancer-center-in-southern-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:30:39Z","timestamp":1777426239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474422-clinical-outcomes-and-therapeutic-response-in-adult-tfe3-related-renal-cell-carcinoma-a-case-series-from-a-tertiary-cancer-center-in-southern-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.107915","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}